Lipoxygenase inhibitor, MK-0591, Purity ≥98%

Synonym: 136668-42-3; Quiflapon; MK0591; MK 0591; 3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoic acid; Lipoxygenase inhibitor

CAS Number: 136668-42-3
Compound CID: 60923

Product Size

10 mg; 50 mg; 100 mg; 200 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

MK-0591 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting lipoxygenase. The molecular weight of the compound is 587.17, and its molecular formula is C₃₄H₃₅ClN₂O₃S.

Molecular Weight

587.17

Molecular Formula

C₃₄H₃₅ClN₂O₃S

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

MK-0591 can be studied extensively for its potential therapeutic applications in the treatment of pain and anxiety disorders by increasing the levels of endocannabinoids, which can modulate pain and mood.